Switch to:
More From Other Websites
VIVUS Announces Date of 2016 First Quarter Business Update and Financial Results Teleconference Apr 19 2016
VIVUS Announces Date of 2016 First Quarter Business Update and Financial Results Teleconference Apr 19 2016
VIVUS (VVUS) Upgraded to Hold on Strong Fundamentals Apr 11 2016
Biotech Volatility Both Good And Bad Apr 07 2016
ETF’s with exposure to VIVUS, Inc. : April 4, 2016 Apr 04 2016
VIVUS (VVUS) in Focus: Stock Jumps 6.4% in Session Apr 04 2016
ETF’s with exposure to VIVUS, Inc. : March 25, 2016 Mar 25 2016
VIVUS INC Financials Mar 15 2016
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 14 2016
ETF’s with exposure to VIVUS, Inc. : March 14, 2016 Mar 14 2016
VIVUS, Inc. :VVUS-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 14 2016
VIVUS Posts Narrower Loss in Q4 but Misses on Revenues Mar 10 2016
Edited Transcript of VVUS earnings conference call or presentation 9-Mar-16 9:30pm GMT Mar 09 2016
Vivus reports 4Q loss Mar 09 2016
Vivus reports 4Q loss Mar 09 2016
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 09 2016
VIVUS INC Files SEC form 10-K, Annual Report Mar 09 2016
VIVUS Reports Fourth Quarter and Year-End 2015 Financial Results Mar 09 2016
Q4 2015 VIVUS Inc Earnings Release - After Market Close Mar 09 2016
VIVUS Announces Date of Fourth Quarter 2015 Update and Financial Results Teleconference Feb 29 2016
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 28 2016
The Zacks Analyst Blog Highlights: Gilead, MannKind, VIVUS and Baxalta Jan 07 2016
Biotech Stock Roundup: MannKind Tanks on Deal Termination, Speedy Review for Gilead Drug Jan 06 2016
VIVUS to Regain U.S. and Canada Stendra Rights from Endo Jan 04 2016
Vivus reports 3Q loss Nov 04 2015
VIVUS Reports Third Quarter 2015 Financial Results Nov 04 2015
VIVUS Announces Date of Third Quarter 2015 Update and Financial Results Teleconference Oct 28 2015
VIVUS, Inc. Board of Directors Expresses No Opinion and Remains Neutral Toward Icahn Group's... Sep 22 2015
Vivus reports 2Q loss Jul 30 2015
VIVUS Reports Second Quarter 2015 Financial Results Jul 30 2015
VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call Jul 23 2015
VIVUS Announces Scientific Presentations May 14 2015
VIVUS Reports First Quarter 2015 Financial Results May 05 2015
Vivus reports 1Q loss May 05 2015
Vivus reports 4Q loss Feb 24 2015
FDA clears Novo Nordisk's weight loss drug Saxenda Dec 23 2014
Orexigen rises as weight loss drug review proceeds Nov 10 2014
Vivus tops Street 3Q forecasts Nov 05 2014
Rite Aid and Pier 1 are big market movers Sep 18 2014
FDA OKs faster-acting label for ED drug Stendra Sep 18 2014
Vivus acquires patent rights to Qsymia ingredient Aug 25 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK